171 related articles for article (PubMed ID: 16935414)
1. Prostate cancer nomograms: an update.
Chun FK; Karakiewicz PI; Briganti A; Gallina A; Kattan MW; Montorsi F; Huland H; Graefen M
Eur Urol; 2006 Nov; 50(5):914-26; discussion 926. PubMed ID: 16935414
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.
Chun FK; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Abbou CC; Stillebroer AB; van Gils MP; Schalken JA; Fradet Y; Marks LS; Ellis W; Partin AW; Haese A
Eur Urol; 2009 Oct; 56(4):659-67. PubMed ID: 19304372
[TBL] [Abstract][Full Text] [Related]
3. Role of nomograms for prostate cancer in 2007.
Chun FK; Karakiewicz PI; Huland H; Graefen M
World J Urol; 2007 Apr; 25(2):131-42. PubMed ID: 17333203
[TBL] [Abstract][Full Text] [Related]
4. A catalog of prostate cancer nomograms.
Ross PL; Scardino PT; Kattan MW
J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer nomograms are superior to neural networks.
Karakiewicz PI; Chun FK; Briganti A; Perrotte P; McCormack M; Bénard F; Valiquette L; Graefen M; Saad F
Can J Urol; 2006 Apr; 13 Suppl 2():18-25. PubMed ID: 16672124
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
7. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy.
Porter CR; Gallina A; Kodama K; Gibbons RP; Correa R; Perrotte P; Karakiewicz PI
Eur Urol; 2007 Aug; 52(2):446-52. PubMed ID: 17140724
[TBL] [Abstract][Full Text] [Related]
9. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI
Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365
[TBL] [Abstract][Full Text] [Related]
10. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Walz J; Gallina A; Saad F; Montorsi F; Perrotte P; Shariat SF; Jeldres C; Graefen M; Bénard F; McCormack M; Valiquette L; Karakiewicz PI
J Clin Oncol; 2007 Aug; 25(24):3576-81. PubMed ID: 17704404
[TBL] [Abstract][Full Text] [Related]
11. An updated catalog of prostate cancer predictive tools.
Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of an extended 10-core biopsy nomogram.
Chun FK; Briganti A; Graefen M; Montorsi F; Porter C; Scattoni V; Gallina A; Walz J; Haese A; Steuber T; Erbersdobler A; Schlomm T; Ahyai SA; Currlin E; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
Eur Urol; 2007 Aug; 52(2):436-44. PubMed ID: 17010505
[TBL] [Abstract][Full Text] [Related]
13. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
[TBL] [Abstract][Full Text] [Related]
14. A novel nomogram to predict the probability of prostate cancer on repeat biopsy.
Benecchi L; Pieri AM; Melissari M; Potenzoni M; Pastizzaro CD
J Urol; 2008 Jul; 180(1):146-9. PubMed ID: 18485383
[TBL] [Abstract][Full Text] [Related]
15. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
Steyerberg EW; Roobol MJ; Kattan MW; van der Kwast TH; de Koning HJ; Schröder FH
J Urol; 2007 Jan; 177(1):107-12; discussion 112. PubMed ID: 17162015
[TBL] [Abstract][Full Text] [Related]
16. Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
Roach M; Weinberg V; Nash M; Sandler HM; McLaughlin PW; Kattan MW
J Urol; 2006 Dec; 176(6 Pt 2):S16-20. PubMed ID: 17084158
[TBL] [Abstract][Full Text] [Related]
17. Information content of five nomograms for outcomes in prostate cancer.
Bismar TA; Humphrey P; Vollmer RT
Am J Clin Pathol; 2007 Nov; 128(5):803-7. PubMed ID: 17951203
[TBL] [Abstract][Full Text] [Related]
18. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
[TBL] [Abstract][Full Text] [Related]
19. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
Dong F; Kattan MW; Steyerberg EW; Jones JS; Stephenson AJ; Schröder FH; Klein EA
J Urol; 2008 Jul; 180(1):150-4; discussion 154. PubMed ID: 18485398
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
Shariat SF; Park S; Trinh QD; Roehrborn CG; Slawin KM; Karakiewicz PI
J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]